Evidence for a cytoskeleton attachment domain at the N-terminus of the NF2 protein.
Neurofibromatosis type 2 is a hereditary cancer syndrome characterized by the development of bilateral vestibular schwannomas. Underlying the disease are inactivating mutations of the NF2 tumor suppressor gene, located on chromosome 22, encoding a 595-amino-acid protein. The NF2 protein, also known as merlin or schwannomin, is reported to act as a membrane-cytoskeleton linking protein. This assumption is based on the homology of the NF2 protein to a group of band 4.1-related proteins, ezrin, radixin, and moesin. The cytoskeletal association of the NF2 protein has in part been confirmed by its ability to resist extraction from cells by nonionic detergents. We performed detergent extraction on COS cells transfected with NF2 cDNA constructs. The extracts were analyzed by Western blotting and immunofluorescent staining with monoclonal anti-NF2 antibodies. The results provide evidence for a high-affinity cytoskeleton attachment domain at amino acids 29-131 and a putative lower affinity domain between amino acids 321 and 470.
den Bakker
M A
MA
Department of Pathology, Josephine Nefkens Institute, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands. denbakker@path.fgg.eur.nl
Riegman
P H
PH
Suurmeijer
A P
AP
Vissers
C J
CJ
Sainio
M
M
Carpen
O
O
Zwarthoff
E C
EC
D000818:Animals; D000911:Antibodies, Monoclonal; D015153:Blotting, Western; D019556:COS Cells; D003599:Cytoskeleton / Q000737:chemistry* / Q000235:genetics; D018076:DNA, Complementary / Q000235:genetics; D008565:Membrane Proteins / Q000737:chemistry* / Q000235:genetics; D009154:Mutation / Q000235:genetics; D016518:Neurofibromatosis 2 / Q000235:genetics; D025581:Neurofibromin 2; D011487:Protein Conformation; D014162:Transfection / Q000379:methods
D000911:Antibodies, Monoclonal; D018076:DNA, Complementary; D008565:Membrane Proteins; D025581:Neurofibromin 2